Parampara Dairy (PARAMPARA)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹11
Market Cap₹11.24 Cr
P/E Ratio59.16
ROCE1.05%
ROE—%
Dividend Yield0%
Profit Growth50%
Debt/Equity—
Sales Growth23.74%
Promoter Holding1.46%
52-Week Range₹10.1 — ₹12.95
SectorIndustrial Products

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me be blunt: at ₹11 a share, Parampara Dairy has the surface of a growth story but not the substance I look for. Sales grew 23.74% and profits 50%, but when the latest quarter delivers ₹10 crore of revenue and essentially zero net profit, those growth rates are flattering a tiny base. Market cap is just ₹11 crore; P/E is 59.16, and PEG 1.60. That is not a margin of safety. ROCE of 1.05% tells me the business is earning very little on the capital employed. A packaging company with this return profile is a capital guzzler, not a compounding machine. Promoter holding is only 1.46% — that alone disqualifies it for me. I cannot trust management that has almost no ownership and does not pay a dividend. Piotroski F-score of 7/9 suggests recent financials are not deteriorating, but Graham would remind me that a few good signals cannot replace a durable moat. There is no meaningful competitive advantage visible; in packaging, scale and efficiency rule, and this company's profitability suggests it has neither. At 52-week range of ₹10.45-₹12.95, the stock is near the low end, but a low price is not automatically cheap. Without book value or debt-equity data, I lack the margin-of-safety analysis I require. I would classify this as a fast grower on paper, but a fragile one. In India's small-cap market, a 1.46% promoter stake is an enormous governance red flag. I will watch from the sidelines until there is evidence of real profitability, improved returns on capital, and serious insider ownership.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer